MHRA - Jobs for 'the boys?'

Watson Names Gordon Munro, Ph.D., Senior Vice President, Quality Assurance

Mar 15, 2004

Watson Pharmaceuticals, Inc., a leading specialty pharmaceutical company, announced today the appointment of Gordon Munro, Ph.D., 57, to Senior Vice President, Quality Assurance. Dr. Munro replaces Donald Britt, who will be retiring later this year.

"We are extremely delighted to welcome Gordon to the Watson organization and to our senior management team," began Allen Chao, Ph.D., Chairman and Chief Executive Officer. "Gordon will bring great industry depth and perspective to our quality organization. Based on his extensive experience in both the industry and the regulatory arena, we believe his leadership can add tremendously to our quality operations," he said

Dr. Munro brings to Watson a unique blend of industry and regulatory experience. His notable contributions in the industry led to an officer appointment with the UK Medicines Control Agency (MCA). During the past seven years, he has held the position of Director, Inspection and Enforcement Division of the United Kingdom Medicines Control Agency, responsible for all inspections related to Good Manufacturing Practices, Good Distribution Practices, Good Laboratory Practices, and Good Clinical Practices;

Most recently, he was Director of Inspection and Enforcement, and Acting Head of Medicines at the Medicines and Healthcare products Regulatory Agency (MHRA)

Prior to the MHRA, Dr. Munro was with GlaxoSmithKline for over 25 years


Unusual - I actually thought ex GSK employees finished their careers at the MHRA!

Breckenridge
Hudson

Jobs for the boys?

Read the new book, The Evidence, However, Is Clear...The Seroxat Scandal

By Bob Fiddaman

ISBN: 978-1-84991-120-7
CHIPMUNKA PUBLISHING

AVAILABLE FOR DOWNLOAD HERE


PAPERBACK COMING SOON